Kapstone Financial Advisors LLC Tekla Life Sciences Investors Transaction History
Kapstone Financial Advisors LLC
- $165 Billion
- Q3 2024
A detailed history of Kapstone Financial Advisors LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Kapstone Financial Advisors LLC holds 11,823 shares of HQL stock, worth $169,068. This represents 0.11% of its overall portfolio holdings.
Number of Shares
11,823Holding current value
$169,068% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
75Shares Held
9.29MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$49 Million1.1% of portfolio
-
Penserra Capital Management LLC Orinda, CA776KShares$11.1 Million0.25% of portfolio
-
Morgan Stanley New York, NY490KShares$7 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY469KShares$6.7 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.96 Million0.14% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...